Clinical Trial Update: Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of eszopiclone in children and adolescents with ADHD-associated insomnia completed; results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia, Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-04-10